The Regulator's Perspective: How Should New Therapies and Follow-On Products for Ms Be Clinically Evaluated in the Future?

AuthID
P-00K-P0M
7
Author(s)
Tipo de Documento
Article
Year published
2016
Publicado
in MULTIPLE SCLEROSIS JOURNAL, ISSN: 1352-4585
Volume: 22, Número: 2 Suppl, Páginas: 47-59 (13)
Indexing
Publication Identifiers
SCOPUS: 2-s2.0-84979496960
Wos: WOS:000380996700006
Source Identifiers
ISSN: 1352-4585
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.